Ardelyx, Inc. (ARDX) vs Ginkgo Bioworks Holdings, Inc. (DNA)
- Ardelyx, Inc. ARDX 3.09 −5.50%
- Ginkgo Bioworks Holdings, Inc. DNA 10.27 −12.67%
Ardelyx, Inc. and Ginkgo Bioworks Holdings, Inc. are both Biotechnology companies. Ardelyx, Inc. and Ginkgo Bioworks Holdings, Inc. are of similar size ($814.9M and $791.9M). Ardelyx, Inc. grew revenue faster over the last twelve months: 16.8% against −37.0%. Ardelyx, Inc. has the higher net margin (−12.4% vs −219.6%) and the higher return on invested capital (−18.6% vs −161.9%). Across the 18 metrics below, Ardelyx, Inc. leads on 13 and Ginkgo Bioworks Holdings, Inc. on 5.
Valuation
Profitability
| Metric | ARDX | DNA | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 68.04% | 65.16% |
| Operating margin | (7.86%) | (231.13%) | 0.00% |
| Net margin | (12.35%) | (219.60%) | 0.00% |
| Free cash flow margin | (3.97%) | (131.57%) | 0.00% |
| Return on equity | (38.61%) | (56.29%) | (56.36%) |
| Return on assets | (10.68%) | (26.19%) | (48.04%) |
| Return on invested capital | (18.62%) | (161.94%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack